(Q3)Jan 31, 2024 | (Q2)Oct 31, 2023 | (Q1)Jul 31, 2023 | |
---|---|---|---|
Operating Cash Flow (Indirect Method) | |||
Cash flow from continuing operating activities | -159.73K | -128.96K | -88.62K |
Net income from continuing operations | ---197.64K | ---124.29K | ---127.8K |
Asset impairment expenditure | ---- | ---- | --0 |
Remuneration paid in stock | ---- | ---- | --0 |
Other non cashItems | --20.33K | --8.64K | --8.4K |
Change In working capital | --17.58K | ---13.3K | --30.77K |
-Change in receivables | ---4.65K | ---4.33K | --60.01K |
-Change in prepaid assets | --0 | --11K | ---8.5K |
-Change in payables and accrued expense | --22.23K | ---19.97K | ---20.74K |
Cash from discontinued investing activities | |||
Operating cash flow | ---159.73K | ---128.96K | ---88.62K |
Investing cash flow | |||
Cash flow from continuing investing activities | -10K | -81.56K | -44.37K |
Net PPE purchase and sale | ---10K | ---81.56K | ---44.37K |
Cash from discontinued investing activities | |||
Investing cash flow | ---10K | ---81.56K | ---44.37K |
Financing cash flow | |||
Cash flow from continuing financing activities | 0 | 0 | |
Net common stock issuance | ---- | --0 | --0 |
Cash from discontinued financing activities | |||
Financing cash flow | ---- | --0 | --0 |
Net cash flow | |||
Beginning cash position | --806.51K | --1.02M | --1.15M |
Current changes in cash | ---169.73K | ---210.51K | ---132.99K |
End cash Position | --636.78K | --806.51K | --1.02M |
Free cash from | ---169.73K | ---210.51K | ---132.99K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.